XTL BIOPHARMACEUTICALS LTD. Increase Decrease In Cash And Cash Equivalents
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Increase Decrease In Cash And Cash Equivalents of -$1.01 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-04-30
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2024-12-31 | -$1.01M 20-F · filed 2025-04-30 | |
| 2023-12-31 | -$666.00K 20-F · filed 2025-04-30 | |
| 2022-12-31 | -$865.00K 20-F · filed 2025-04-30 | |
| 2022-06-30 | -$612.00K 6-K · filed 2022-08-24 | |
| 2021-12-31 | -$656.00K 20-F · filed 2023-03-22 | |
| 2021-06-30 | -$712.00K 6-K · filed 2022-08-24 | |
| 2020-12-31 | -$818.00K 20-F · filed 2023-03-22 | |
| 2019-12-31 | $1.20M 20-F · filed 2022-03-30 |